Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment - Wikidata - wikimedia - TriplyDB

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment

http://www.wikidata.org/entity/Q34475350

about

Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment The current and future role of magnetic resonance imaging in prostate cancer detection and management Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS Multiparametric-MRI in diagnosis of prostate cancer The role of MRI in prostate cancer diagnosis and management.Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers A critical comparison of techniques for MRI-targeted biopsy of the prostate.Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.Clinicopathologic differences between prostate cancers detected during initial and repeat transrectal ultrasound-guided biopsy in Korea.The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.Multiparametric MRI guidance in first-time prostate biopsies: what is the real benefit?Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.Accuracy of Elastic Fusion of Prostate Magnetic Resonance and Transrectal Ultrasound Images under Routine Conditions: A Prospective Multi-Operator Study.The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population.The role of imaging in the diagnosis of primary prostate cancer.Histopathological screening for prostate carcinoma: is a benign biopsy a negative biopsy?Biopsy sampling and histopathological markers for diagnosis of prostate cancer.Will Multi-Parametric Magnetic Resonance Imaging be the Future Tool to Detect Clinically Significant Prostate Cancer?Multiparametric MRI-targeted TRUS prostate biopsies using visual registration.The role of MRI in active surveillance for prostate cancer.MRI-guided biopsies and minimally invasive therapy for prostate cancer.Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET.Role of prostate magnetic resonance imaging in active surveillance.Evaluating the Role of mpMRI in Prostate Cancer Assessment.Multi-parametric MRI imaging of the prostate-implications for focal therapy.MRI-fusion biopsy: the contemporary experience.Accurate prediction tools in prostate cancer require consistent assessment of included variables.Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.Methodology to study the three-dimensional spatial distribution of prostate cancer and their dependence on clinical parameters.Direct MRI-guided biopsy of the prostate: use of post-biopsy needle track imaging to confirm targeting.Peripheral zone volume ratio (PZ-ratio) is relevant with biopsy results and can increase the accuracy of current diagnostic modality.Computer aided detection in prostate cancer diagnostics: A promising alternative to biopsy? A retrospective study from 104 lesions with histological ground truth.Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study.Nonrigid Registration of Prostate Diffusion-Weighted MRI.HistoScanningTM to Detect and Characterize Prostate Cancer-a Review of Existing Literature.The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance.

P2860

Q26749212-D8A090A8-6AF4-45FE-9183-2E13D8E162E6 Q26773645-ED8D25C8-6A0E-4645-B65B-F98D5AF864DC Q26801576-374E0CCB-7CCD-4F45-A434-1898BEBE1C6E Q28068102-764D5072-914A-48AC-9561-A9C3DD72D5F3 Q28081873-40E65E35-0631-4CD2-AD90-78312BEBD61E Q30245245-ADA18C87-763C-41FD-ADF4-C4F1D337D7BD Q33796352-C56E59C3-B1FF-47E8-81C1-9E440580958C Q33890165-6913D075-823E-4FBC-B491-971D86BB3942 Q33890201-6AAD0FE6-D28E-4373-82CE-6F0702F77382 Q34506849-3A41EB2F-9556-4AD4-BB22-9CBEA438FD02 Q35735296-B4763E8A-F57B-49C8-B1FB-2D9857D838DC Q35838209-B362E84C-D854-4C71-9962-35DB8046EB4D Q36039090-4B49A408-9396-4414-A0F3-DCBC81E5FF78 Q36049175-93CDCFE2-0663-420B-A2F1-2746BD695D90 Q36235830-178A3370-86D4-462C-ACA1-1E410E4FFE7C Q36337051-3CE17153-3F03-4753-A918-5926D2EF25B5 Q36522791-CE46E79D-6613-4A49-9EF9-ADBF585BD1AC Q37665327-122831D2-5334-462A-9196-4EE4AE739490 Q37708182-8E8D9A30-E2AE-46BE-8903-E30A92514073 Q38232146-6DDC6473-8F0D-4570-B313-C9143EC88A5D Q38256309-67E324A8-6F31-4F15-9C9D-95A2030B777A Q38269520-A8601552-1CDE-4271-B8B8-667A540B5564 Q38294506-DE99C429-639C-4C91-9DBF-9051F04FE028 Q38504909-70A4FABB-7F4D-42BC-8B87-874FFBA41501 Q38545811-CD155FEF-54AC-499C-B50D-5CDE1AC0F907 Q38606252-65869EC1-EC2D-4E67-AF87-1E13F999844D Q38671172-7082BEB5-5EE7-45E4-BF28-298DDA9C087E Q38675322-FB9FA4DE-3972-448C-97FE-E8802D72CE67 Q39446420-576C4E49-F2FD-47B0-A684-39BF99D7CAE0 Q39446434-BF746A18-2B96-41CD-A558-195CA9366185 Q39882385-09DD0725-A3E2-4EF0-B080-D43F41DE39AC Q39947142-1A89F0B4-0C2A-45A7-9E1D-D0F7EEEB240E Q40302020-FFE3F8A3-D066-40FE-B557-C20B14BC7E60 Q42083450-388BC20D-76DF-43C0-9C2D-C308F1F132E4 Q42202657-3B7834F9-4097-4C51-9C92-9254B8324E60 Q42375733-B010AE12-B70C-4CD0-8023-9A08F81313CF Q42376791-87895D37-BD98-40A5-A878-7C06C6E08F98 Q42927491-0958A2DF-D746-4E2F-93F6-A6CBA4D09D6D Q47731511-10FD7C2E-B52B-481B-874D-067E62BBDF35 Q48293477-1D3F313C-312A-4039-9C80-BDFF8CA8F228

P2860

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment

http://www.wikidata.org/entity/Q34475350

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Optimization of prostate biops ...... calization and risk assessment

@ast

Optimization of prostate biops ...... calization and risk assessment

@en

Optimization of prostate biops ...... calization and risk assessment

@nl

type

label

Optimization of prostate biops ...... calization and risk assessment

@ast

Optimization of prostate biops ...... calization and risk assessment

@en

Optimization of prostate biops ...... calization and risk assessment

@nl

prefLabel

Optimization of prostate biops ...... calization and risk assessment

@ast

Optimization of prostate biops ...... calization and risk assessment

@en

Optimization of prostate biops ...... calization and risk assessment

@nl

P1433

Q34475350-A13986D4-78D3-4AFE-BA3C-D4F5FC443C78

P1476

Q34475350-23801A83-F784-4BD3-A47B-CFE96C0D734C

P2093

Q34475350-05B27CA9-6F36-4D01-B61A-C96E2DE2624C

Q34475350-30E7D070-2FAD-4AEA-B81A-916B90390D52

Q34475350-5E2C05B4-F086-4301-BBE3-5F89D2C1A762

Q34475350-68E097A9-EAB2-43B7-B39C-FF4A4E67924F

Q34475350-758187C6-9273-46AD-99AD-CCBF72127FBB

Q34475350-EEED4B07-E190-4873-80EE-BA7AA32E7F72

P2860

Q34475350-00445E36-58FB-4D41-85C5-6B5203C21DDC

Q34475350-196F57B8-1AE5-467F-9137-B10456D2C2CA

Q34475350-1AB2DAF1-CD61-4195-BA3D-72F4EBEA791B

Q34475350-1EF0EF1E-5BE4-4427-9F69-000EB7B34B04

Q34475350-1FF976A8-27FC-492D-940C-1522076B612D

Q34475350-262E1E69-79C3-4221-AE6E-FDC8B6AEE644

Q34475350-26E75ABF-833E-4C6E-8F86-29103EE8CEF9

Q34475350-3132487A-1CD7-4E57-9921-93CEEF8AC2AA

Q34475350-3406C360-E2EB-42DD-BE84-F84E38C74DA8

Q34475350-34C1E97B-BA52-4821-A938-D67F6CDA3752

P304

Q34475350-FCDC5C5E-9481-4563-B9CF-60656DE1E086

P31

Q34475350-8EA99531-6BA2-4DC8-82B0-046A88CB8962

P356

Q34475350-C5B9C0E0-42B9-4E4F-A815-4852DDF2EE3F

P407

Q34475350-CBEEBD98-E40B-4A9C-BEDE-E739AF6A094E

P433

Q34475350-21622027-8D49-4CAD-B644-EFFB01EC0D53

P478

Q34475350-8827F175-38E7-4282-AD4A-1A9E64035F69

P50

Q34475350-BECCC376-F2AF-4008-97F3-9BF476D86141

P577

Q34475350-A8294926-41E6-4F2F-BE18-2ED6EF726032

P698

Q34475350-F623E755-2001-4B3E-B715-4DCF7FC04A3D

P921

Q34475350-CA9D9975-10FD-4CCE-B435-F7870B0AD8D0

P932

Q34475350-D82BD920-9E5A-4B66-AAA7-173E59912125

P356

J.JURO.2014.03.117

P1433

The Journal of Urology

P1476

Optimization of prostate biops ...... calization and risk assessment

@en

P2093

Herbert Lepor

http://www.w3.org/2001/XMLSchema#string

James S Wysock

http://www.w3.org/2001/XMLSchema#string

Julien Le Nobin

http://www.w3.org/2001/XMLSchema#string

Marc A Bjurlin

http://www.w3.org/2001/XMLSchema#string

Samir S Taneja

http://www.w3.org/2001/XMLSchema#string

Xiaosong Meng

http://www.w3.org/2001/XMLSchema#string

P2860

ESUR prostate MR guidelines 2012

Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort

Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies

Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging.

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device

P304

648-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2014.03.117

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P50

Andrew B Rosenkrantz

P577

2014-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24769030

http://www.w3.org/2001/XMLSchema#string

P921

P932

4224958

http://www.w3.org/2001/XMLSchema#string